OpenAlex
PricingAboutJobs
Log inGet started
Work

MA01.05 Tislelizumab Plus Chemotherapy Followed by Surgery or Radiotherapy and Adjuvant Tislelizumab in Unresectable Stage III NSCLC

HTML

Year: 2025
Type: conference-abstract
Source: Journal of Thoracic Oncology
DOI: 10.1016/j.jtho.2025.09.100
Authors: J. Liu, L. Tu, Y. Li, Y. Li, Z. Li, T. Wang, T. Wang, Q. Wu, L. Wang, X. Zhai, J. Dong, M. Fan, P. Tian, D. Pu, Y. Zhang, F. Luo, Y. Liu, J. Wang, F. Xu, Y. Lai, K. Wang, X. Zheng, G. Che
Institutions: Sichuan University, West China Hospital of Sichuan University
Language: English

Topic: Lung Cancer Diagnosis and Treatment
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: tislelizumab, non-small cell lung cancer, stage III NSCLC, unresectable disease, chemotherapy, surgery, radiotherapy, adjuvant immunotherapy, immune checkpoint inhibitors
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W4415520439
Cites:
Cited by: 4
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security